PULMATRIX
Pulmatrix is a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology. The Company's proprietary product pipeline is initially focused on advancing treatments for serious lung diseases, including Pulmazole, an inhaled anti-fungal for patients with ABPA, and PUR1800, a narrow spectrum kinase inhibitor in lung cancer. Pulmatrix's product candidates are based on iSPERSE™, its proprietary engineered dry powder delivery platform, which seeks to improve therapeutic delivery to the lungs by achieving optimal local drug concentrations and reducing systemic side effects to improve patient outcomes.
PULMATRIX
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2003-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.pulmatrix.com
Total Employee:
11+
Status:
Active
Contact:
(781)357-2399
Email Addresses:
[email protected]
Total Funding:
148.42 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Font Awesome Apache Microsoft Exchange Online Office 365 Mail IPv6
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Mapp Biopharmaceutical
Mapp Biopharmaceutical was created to develop novel pharmaceuticals for the prevention and treatment of infectious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Heart, Lung and Blood Institute
National Heart, Lung and Blood Institute investment in Grant - Pulmatrix
Polaris Partners
Polaris Partners investment in Post-IPO Equity - Pulmatrix
ARCH Venture Partners
ARCH Venture Partners investment in Post-IPO Equity - Pulmatrix
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Post-IPO Equity - Pulmatrix
5AM Ventures
5AM Ventures investment in Post-IPO Equity - Pulmatrix
Polaris Partners
Polaris Partners investment in Series B - Pulmatrix
5AM Ventures
5AM Ventures investment in Series B - Pulmatrix
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Pulmatrix
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Pulmatrix
5AM Ventures
5AM Ventures investment in Series B - Pulmatrix
Official Site Inspections
http://www.pulmatrix.com Semrush global rank: 5.07 M Semrush visits lastest month: 1.63 K
- Host name: 209.114.180.107.host.secureserver.net
- IP address: 107.180.114.209
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Pulmatrix"
PULMATRIX, INC. - Crunchbase Company Profile
Pulmatrix is a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology. The Company's proprietary product …See details»
Our Story - PULMATRiX
PULMATRiX is committed to the development and commercialization of novel and transformational medicines for patients all over the world, using our proprietary iSPERSE ™ technology to optimally deliver both respiratory and …See details»
PULMATRiX
Pulmatrix is a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases and central nervous system (“CNS”) disorders using …See details»
Pulmatrix, Inc. - AnnualReports.com
Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ …See details»
Pulmatrix, Inc. (PULM) Company Profile & Facts - Yahoo Finance
See the company profile for Pulmatrix, Inc. (PULM) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
Pulmatrix Inc. - LinkedIn
PULMATRIX is committed to the development and commercialization of novel and transformational medicines for patients all over the world, using our proprietary iSPERSE™ …See details»
PULMATRiX | White Rose Wiki
Jun 14, 2023 PULMATRiX is an American pharmaceutical company based in Lexington, Massachusetts. ¶ Organization. Name Position Notes; Ciaran Lawlor: Senior Scientist (former) …See details»
Pulmatrix - Crunchbase Company Profile & Funding
Organization. Pulmatrix . Connect to CRM . Save . Summary. People. Technology. Signals & News. About. PULMATRIX is novel and transformational medicines for patients all over the …See details»
Pulmatrix, Inc. (PULM) Company Profile & Overview - Stock Analysis
1 day ago Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with …See details»
PULMATRIX Corporate Overview
By Pulmatrix should fully fund the company beyond the Pulmazole Ph2 study data Cipla is India’s 2ndlargest pharmaceutical company with global presence in over 130 countries, over 35 …See details»
PULMATRIX, INC. - Funding, Financials, Valuation & Investors
PULMATRIX, INC. is registered under the ticker NASDAQ:PULM . Their stock opened with $7.20 in its Mar 28, 2014 IPO. PULMATRIX, INC. is funded by 6 investors. National Heart, Lung and …See details»
Investors - PULMATRiX
Our innovative particle engineering technology creates dry powder, which solves limitations of conventional inhaled technologies and expands the universe of inhalable drug therapies.See details»
PULMATRiX
Nov 13, 2024 Information about Pulmatrix's directors and executive officers, including a description of their interests in Pulmatrix, is included in Pulmatrix's most recent Annual Report …See details»
Pulmatrix Company Profile - Office Locations, Competitors, …
Oct 29, 2024 Pulmatrix, Inc., a clinical-stage biopharmaceutical company, develops inhaled therapies for the treatment, prevention, and transmission control of infectious and progressive …See details»
PULMATRiX
PULMATRiX . OUR STORY. Our Story Our Mission About ABPA About AECOPD Our Innovation. iSPERSE™ iSPERSE™ Benefits ...See details»
Leadership - PULMATRiX
Mr. Kramer is responsible for the Quality function in addition to overseeing the safety and facilities functions at PULMATRIX. Since joining the company in 2009, Mr. Kramer has progressed …See details»
Pulmatrix - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Pulmatrix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Pulmatrix has 4 current employee profiles, including …See details»
PULMATRiX
Nov 13, 2024 At Pulmatrix, we are committed to communicating clear and consistent information. Here we feature current and historic content concerning our science, our pipeline, …See details»
Leadership - PULMATRiX
Peter Ludlum Interim Chief Executive Officer. Mr. Ludlum is an experienced financial executive with over 23 years of work with early-stage and high growth companies within the life science …See details»